Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
417

Summary

Conditions
Metastatic Breast Cancer
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01942135
Collaborators
AstraZeneca
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer